ArticleAnti-cancer drugs2025

Anlotinib for the treatment of pulmonary epithelioid inflammatory myofibroblastic sarcoma: a case report.

Huanling Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.